Fixplan 200 IU/ml lyophilisate and solvent for solution for injection
Fixplan 200 IU/ml lyophilisate and solvent for solution for injection
Authorised
- Gonadotropin, equine, serum
Product identification
Medicine name:
Fixplan 200 IU/ml lyophilisate and solvent for solution for injection
Fixplan 200 I.E./ml Lyophilisat und Lösungsmittel zur Herstellung einer Injektionslösung für Rinder, Schafe, Schweine
Active substance:
- Gonadotropin, equine, serum
Target species:
-
Cattle
-
Sheep
-
Pig
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Gonadotropin, equine, serum200.00international unit(s)1.00millilitre(s)
Pharmaceutical form:
-
Lyophilisate and solvent for solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal0day
-
Milk0hour
-
-
Sheep
-
Meat and offal0day
-
Milk0hour
-
-
Pig
-
Meat and offal0day
-
-
-
Subcutaneous use
-
Pig
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QG03GA03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Available in:
-
Germany
Package description:
- Lyophilisate: 8 ml colourless type I glass vial closed with a grey bromobutyl rubber stopper, aluminium seals and prolypropylene caps. Solvent: 30 ml colourless type II glass vial closed with a grey bromobutyl rubber stopper, aluminium seals and polypropylene caps. Carton box containing 1 vial of 5,000 IU lyophilisate and 1 vial of solvent (25 ml).
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Syn Vet-Pharma Ireland Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- V.M.D.
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 402695.00.00
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0448/001
Concerned member states:
-
Belgium
-
France
-
Germany
-
Hungary
-
Italy
-
Netherlands
-
Poland
-
Portugal
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 26/01/2025
German (PDF)
Published on: 27/02/2025
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 27/02/2025
How useful was this page?: